The findings in the paper entitled “A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain” were made in collaboration between DANDRITE-affiliated researchers Christian B. Vægter and Mette Richner and researchers from University of Copenhagen.
2020.09.07 | Magnus Kræpping Andersen
Data in the picture show: “Neuropathic pain is characterized by hypersensitivity to temperature and touch as well as spontaneous outburst of pain. This study identifies a peptide that can inhibit PICK1 and thereby interfere with insertion of excess glutamate receptor underlying the hypersensitivity in neuropathic pain.”
Link to full article:
https://www.embopress.org/doi/full/10.15252/emmm.201911248